SpotifyToMP3
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

JAMA Network... · 14:07 · 941 plays

From the album JAMA Neurology Author Interviews

Description

Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD. Related Content: High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

More By JAMA Network...

You May Also Like